Market Research Logo

MediPoint: Viscosupplementation - Global Analysis and Market Forecasts

MediPoint: Viscosupplementation - Global Analysis and Market Forecasts

Summary

Osteoarthritis (OA) constitutes a growing public health burden, and is the most common cause of musculoskeletal disability around the world. Resulting from a complex interaction of biomechanical, biochemical, and genetic factors, OA develops slowly and is characterized by the degradation of the affected joint’s cartilage and bone hypertrophy. The disability is accompanied by joint pain, stiffness, and loss of range of motion. Initially treated with various therapies including physical therapy and nonsteroidal anti-inflammatory drugs (NSAIDs), advanced cases of OA have traditionally been treated surgically. However, intra-articular viscosupplementation with hyaluronic acid (HA), a high-molecular-weight glycosaminoglycan, has become an increasingly accepted therapeutic alternative to knee replacement surgery in the symptomatic management of OA over the past decade.

Global viscosupplementation market was estimated at $2.1B in 2016 spanning 39 markets. By the end of the forecast period in 2023, it is estimated that the market will grow to approximately $3.1B at a Compound Annual Growth Rate (CAGR) of 6.0%.

Key drivers of the viscosupplementation market are -

  • The rising prevalence of osteoarthritis (OA) due to increasing aging and obese populations.
  • The evolving multimodal treatment paradigm for OA.
  • Patients seeking to delay knee replacement surgery in an effort to maintain an active lifestyle.
South America viscosupplementation market is projected to grow at a CAGR of 6.7% during the forecast period, followed by North America, APAC, Middle East and Africa at a CAGR of 6.4%, 6.3% and 5.0% respectively. The European viscosupplementation market is projected to grow at a CAGR of 3.5% during the forecast period. The US represented the largest portion of the market in 2016, holding 95.7% of the regional revenue, and is expected to maintain this dominance through the forecast period.

The market for viscosupplementation is highly fragmented, with key players varying by region and country. Unlike most orthopedic device markets, the market for viscosupplementation is largely populated by pharmaceutical companies. Although many companies maintain a direct presence in the markets they sell to, some have coordinated marketing and distribution partnerships with major orthopedic players in an effort to leverage geographical experience and existing relationships with orthopedic surgeons.

The report MediPoint: Viscosupplementation - Global Analysis and Market Forecasts, focuses on the market outlook for viscosupplementation globally. This report analyzes and discusses the major drivers and barriers of viscosupplementation adoption, and provides an in-depth understanding of the future outlook for this market by geography, with an overall emphasis on the current and future trends in the seven countries.

Companies mentioned in this report: Anika Therapeutics, Ferring Pharmaceuticals, Fidia Farmaceutici, Sanofi, Seikagaku Corporation.

Scope
  • Outlook of sales volume, pricing trends, revenue trends with 2016 as base year and forecasts until 2023, for viscosupplementation.
  • Company share analysis in 2016, for viscosupplementation.
  • Market insights and competitive assessment of the key players within the viscosupplementation market.
Reasons to buy
  • Identify the unmet needs and understand physicians’ perceptions of the current viscosupplementation products
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global viscosupplementation market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors


Table of Contents
1 About the Authors
1.1 Analysts
1.1.1 Jennifer Ryan, Orthopedic Analyst, Medical Devices
2 Table of Contents
2.1 List of Tables
2.2 List of Figures
3 Executive Summary
3.1 Overview
3.2 Market Dynamics
3.3 Key Players in the Viscosupplementation Market
3.4 Viscosupplementation Market Future Outlook
4 Introduction
4.1 Catalyst
4.2 Related Reports
4.3 Upcoming Related Reports
5 Market Outlook
5.1 Procedure Trends
5.2 Pricing Trends
5.3 Revenue Trends
5.4 Company Share Analysis
6 Market Insights
6.1 North America
6.1.1 Canada
6.1.2 Mexico
6.1.3 US
6.2 Europe
6.2.1 Denmark, Finland, Norway, and Sweden
6.2.2 Belgium, France, and Netherlands
6.2.3 Germany and Switzerland
6.2.4 UK and Ireland
6.2.5 Italy, Portugal, and Spain
6.2.6 Austria, Czech Republic, Hungary, and Poland
6.2.7 Greece, Russia, and Turkey
6.3 APAC
6.3.1 Australia and New Zealand
6.3.2 China and Taiwan
6.3.3 India
6.3.4 Japan
6.3.5 South Korea
6.4 South America
6.4.1 Brazil
6.4.2 Argentina and Chile
6.5 Middle East and Africa
6.5.1 Israel
6.5.2 South Africa
6.5.3 Egypt, Saudi Arabia, and UAE
7 Competitive Assessment
7.1 Overview
7.2 Anika Therapeutics
7.2.1 Overview
7.2.2 Portfolio Assessment
7.2.3 Competitive Positioning
7.3 Chugai Pharmaceutical
7.3.1 Overview
7.3.2 Portfolio Assessment
7.3.3 Competitive Positioning
7.4 Ferring Pharmaceuticals
7.4.1 Overview
7.4.2 Portfolio Assessment
7.4.3 Competitive Positioning
7.5 Fidia Farmaceutici
7.5.1 Overview
7.5.2 Portfolio Assessment
7.5.3 Competitive Positioning
7.6 Meda AB (Mylan)
7.6.1 Overview
7.6.2 Portfolio Assessment
7.6.3 News and Deals Analysis
7.6.4 Competitive Positioning
7.7 Sanofi
7.7.1 Overview
7.7.2 Portfolio Assessment
7.7.3 Competitive Positioning
7.8 Seikagaku Corporation
7.8.1 Overview
7.8.2 Portfolio Assessment
7.8.3 Competitive Positioning
7.9 Other Players
8 Appendix
8.1 Bibliography
8.2 Abbreviations
8.3 Methodology
8.3.1 Overview
8.3.2 Coverage
8.3.3 Secondary Research
8.3.4 Forecasting Methodology
8.3.5 Primary Research Summary
8.4 About MediPoint
8.5 About GlobalData
8.6 Contact Us
8.7 Disclaimer
List of Tables
Table 1: Key Metrics in the Global Viscosupplementation Market
Table 2: North America Viscosupplementation Volume Forecast, 2014-2023
Table 3: Europe Viscosupplementation Volume Forecast, 2014-2023
Table 4: APAC Viscosupplementation Volume Forecast, 2014-2023
Table 5: South America Viscosupplementation Volume Forecast, 2014-2023
Table 6: Middle East and Africa Viscosupplementation Volume Forecast, 2014-2023
Table 7: North America Viscosupplementation Average Selling Price Forecast ($), 2014-2023
Table 8: Europe Viscosupplementation Average Selling Price Forecast ($), 2014-2023
Table 9: APAC Viscosupplementation Average Selling Price Forecast ($), 2014-2023
Table 10: South America Viscosupplementation Average Selling Price Forecast ($), 2014-2023
Table 11: Middle East and Africa Viscosupplementation Average Selling Price Forecast ($), 2014-2023
Table 12: North America Viscosupplementation Market Revenue Forecast ($M), 2014-2023
Table 13: Europe Viscosupplementation Market Revenue Forecast ($M), 2014-2023
Table 14: APAC Viscosupplementation Market Revenue Forecast ($M), 2014-2023
Table 15: South America Viscosupplementation Market Revenue Forecast ($M), 2014-2023
Table 16: Middle East and Africa Viscosupplementation Market Revenue Forecast ($M), 2014-2023
Table 17: North America Viscosupplementation Company Share Analysis, 2016
Table 18: Europe Viscosupplementation Company Share Analysis, 2016
Table 19: APAC Viscosupplementation Company Share Analysis, 2016
Table 20: South America Viscosupplementation Company Share Analysis, 2016
Table 21: Middle East and Africa Viscosupplementation Company Share Analysis, 2016
Table 22: Anika Therapeutics - Key Marketed Products Assessment
Table 23: Chugai Pharmaceutical - Key Marketed Products Assessment
Table 24: Ferring Pharmaceuticals - Key Marketed Products Assessment
Table 25: Fidia Farmaceutici - Key Marketed Products Assessment
Table 26: Fidia Farmaceutici - Key Clinical Trials
Table 27: Meda AB - Key Marketed Products Assessment
Table 28: Sanofi - Key Marketed Products Assessment
Table 29: Seikagaku Corporation - Key Marketed Products Assessment
Table 30: Seikagaku Corporation - Key Pipeline Products Assessment
Table 31: Summary of Other Players in the Viscosupplementation Market, 2017
List of Figures
Figure 1: Viscosupplementation Sales for North America, by Country, 2016 and 2023
Figure 2: Viscosupplementation Sales for Europe, by Country, 2016 and 2023
Figure 3: Viscosupplementation Sales for APAC, by Country, 2016 and 2023
Figure 4: Viscosupplementation Sales for South America, by Country, 2016 and 2023
Figure 5: Viscosupplementation Sales for the Middle East and Africa, by Country, 2016 and 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report